Mannitol Injection USP 25 %

Mannitol Injection USP 25% is a sterile solution used for various medical purposes, including fluid replacement and reducing intracranial pressure. This intravenous solution is manufactured by Pfizer Canada ULC.

Mannitol Injection USP 25% is commonly used for fluid replacement and to reduce intracranial pressure. It may also be used to promote diuresis, which helps the body eliminate excess fluid. This solution is administered intravenously and is often used in clinical settings where rapid fluid replacement or pressure reduction is needed.

Mannitol Injection USP 25% works by drawing water out of tissues and into the bloodstream, which can help reduce swelling and pressure. This effect can lead to increased urine output, aiding in the removal of excess fluids from the body. The solution is designed to be quickly absorbed and distributed throughout the body.

Mannitol Injection USP 25% should be used with caution in patients with certain medical conditions, such as heart failure or kidney problems. It is important to follow the instructions provided by a healthcare professional when administering this solution. Always check the packaging for any specific warnings or precautions.

Mannitol Injection USP 25% may interact with other medications, particularly those that affect fluid balance or kidney function. It is important to inform your healthcare provider about all medications you are taking before using this solution. Avoid using this product with alcohol or other substances that can affect hydration levels.